Lisata Therapeutics Stock (NASDAQ: LSTA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 34.80K / 15.92K |
Day Range | - - - |
52 Wk Range | 1.95 - 3.87 |
Market Cap | $29.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 0.22% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lisata Therapeutics (NASDAQ:LSTA) through any online brokerage.
Other companies in Lisata Therapeutics’s space includes: Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
There is no analysis for Lisata Therapeutics.
Lisata Therapeutics has a consensus price target of $15.00.
The stock price for Lisata Therapeutics (NASDAQ: LSTA) is $3.55 last updated Today at July 18, 2024 at 9:02 AM EDT.
There are no upcoming dividends for Lisata Therapeutics.
Lisata Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Lisata Therapeutics.
Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.